Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].

Therapeutische Umschau. Revue therapeutique - 1 Jul 2010

Bürki Nicole

Abstract excerpt

Nowadays, women develop breast and ovarian cancer more and more early. Therefore, gynecologists and primary care physicians encounter the question, whether one of their patients has a genetic predisposition for cancer. They are crucial in initiating a referral for genetic counseling as well as in caring for high risk individuals coming up with questions concerning intensified cancer screening, chemoprevention or...

Topics

Join the communities discussing this publication.

Breast Neoplasms
Early Diagnosis
Genetic Carrier Screening
Genetic Counseling
Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Molecular Probe Techniques

Ovarian Neoplasms

Source

Identifiers

PMID: 20577964
DOI: 10.1024/0040-5930/a000064

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].PMID 20577964Read ↗

[Clinical-genetic care of BRCA-mutation carrier women: prevention, diagnosis and therapy].Semantic proximity Read ↗

[Who must be referred for genetic counseling?]Semantic proximity Read ↗

BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.Semantic proximity Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

[Hereditary predisposition for the development of breast and ovarian carcinoma].Semantic proximity Read ↗

[Peculiarities of diagnosis, treatment and prevention of hereditary cancer of the breast and ovary. Clinical and genetic screening among BRCA1/2 mutation carriers and individuals with high family risk of cancer].Semantic proximity Read ↗

[Recommended Extension of Indication Criteria for Genetic Testing of BRCA1 and BRCA2 Mutations in Hereditary Breast and Ovarian Cancer Syndrome].Semantic proximity Read ↗

[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].Semantic proximity Read ↗

[Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening].Semantic proximity Read ↗

[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary].Semantic proximity Read ↗

Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.Semantic proximity Read ↗

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.